CRISPR as a research tool in cancer and regenerative medicine

May 25, 2023 May 26, 2023


CRISPR Functional Genomics
View Organizer Website


Andreas Vesalius Lecture Hall, Karolinska Institutet
Berzelius väg 3
Solna, 171 65 Sweden
+ Google Map

CRISPR as a research tool in cancer and regenerative medicine

May 25 @ 08:00 May 26 @ 17:00 CEST

International Symposium

This two-day event will bring together leading international experts in the field of CRISPR technology and CRISPR applications in basic research in cancer and regenerative medicine. Attendees will have the opportunity to gain a deeper understanding of the potential and limitations of CRISPR as a research tool, both in precision genome engineering and in massively parallel, functional genomics applications and unbiased screens.

There will be a poster session, and short talks will be chosen from submitted abstracts. This event will provide a valuable opportunity for students, researchers, educators, and industry professionals to learn about the latest developments and applications of this exciting and rapidly advancing field. PhD students are encouraged to submit a poster abstract to obtain educational credits towards their PhD. Come join us and learn how CRISPR can accelerate YOUR research!

The registration fee of 1,000 SEK (excl. VAT) includes access to the conference, lunches and coffee on 25-26 May 2023, as well as snacks and drinks at the poster session on May 25. According to Swedish and EU legislation 25% VAT will be added to the registration fee before payment. 



Confirmed Speakers

Expanding the CRISPR screening toolbox with Cas12a, base editors, and more
John Doench, Broad MIT
Better genome editing by listening to the cells
Jacob Corn, ETH Zurich
Fine-tuning of transcription factor expression dosage uncovers non-linear effects in regulatory networks
Tuuli Lappalainen, KTH and New York Genome Center
Uncovering key resistance mechanisms to cancer immunotherapy
Yumeng Mao, Uppsala University
Harnessing the CRISPR toolbox to engineer biology
Randall J. Platt, ETH Zurich
Target discovery – arrayed & pooled CRISPR screening to drive drug discovery
Douglas Ross-Thriepland, AstraZeneca & CRUK Functional Genomics Centre
New frontiers in pooled CRISPR screens
Neville Sanjana, New York Genome Center
CRISPR discovery platforms for human T cell therapies
Eric Shifrut, Tel Aviv University


Bernhard Schmierer, CRISPR Functional Genomics/Karolinska Institutet
Fredrik Wermeling, Karolinska Institutet (Wermeling lab website)



Last updated: 2023-05-24

Content Responsible: David Gotthold(